(XRAY) Dentsply International Reports In-Line
Dentsply International Inc. (XRAY) reported third quarter earnings per share of 44 cents, in-line with the Zacks Consensus Estimate, but lower than the year-ago earnings of 46 cents. Net sales in the...
View Article(XRAY) DENTSPLY International Analysts Initiate Coverage as Neutral
We recently initiated coverage on DENTSPLY International Inc. (XRAY) with a Neutral recommendation. We rate the stock Neutral with a target price of $37 based on a P/E of 18.3x our 2010 EPS estimate of...
View Article(APOG) Company News for June 23, 2011 – Corporate Summary
• Shares of Robbins & Myers, Inc. (NYSE:RBN) jumped 8.77% on strong fiscal third-quarter profits. The energy equipment supplier said strong customer demand and the recent acquisition of oilfield...
View Article(XRAY) DENTSPLY Grabs Astra Tech for $1.8 Billion
In a bid to bolster its foothold in the global dental market, leading dental products maker DENTSPLY International (XRAY) has agreed to buy Astra Tech, the dental implant division of multinational drug...
View Article(KCI) Kinetic Concepts Aquired by Apax Partners and Two Canadian Pension Funds
Private equity firm Apax Partners and two Canadian pension funds are set to acquire leading medical technology company Kinetic Concepts (KCI). The deal, including Kinetic’s outstanding debt, is valued...
View Article(XRAY) DENTSPLY International – Bull of the Day
We upgrade our recommendation on DENTSPLY International (XRAY) to Outperform based on our improved visibility on the stock. Its second-quarter fiscal 2011 revenues and earnings topped the Zacks...
View Article(ALGN) Align Technology Beats The Street – Margins Lag
Align Technology (ALGN) reported third quarter 2011 adjusted EPS of 27 cents, beating the Zacks Consensus Estimate of 20 cents as well as the year-ago quarter adjusted EPS by 2 cents. Reported EPS was...
View Article(XRAY) DENTSPLY International – Bull of the Day
We reaffirm our Outperform recommendation on DENTSPLY International (XRAY). Its third-quarter fiscal 2011 revenues and earnings outperformed the Zacks Consensus Estimates. Revenues were boosted by...
View Article(JNJ) Pharma & Biotech Stock Review & Outlook – Industry Outlook
With 2011 coming to an end, the pharmaceutical industry continues to face challenges like sluggish prescription trends, EU pricing pressure, intensifying generic competition, pipeline failures and...
View Article(ALGN) Align Technology Posts Solid First Quarter Earnings
Align Technology (ALGN) reported first quarter 2012 EPS of 26 cents, which was 30% higher than the year-ago level. Adjusting for certain one-time items, the adjusted EPS came in at 27 cents, beating...
View Article(ALGN) Align Technology Beats The street in Second Quarter
Align Technology (ALGN) reported second quarter 2012 EPS of 34 cents, considerably higher than the year-ago level of 14 cents. Adjusting for certain one-time items, adjusted EPS came in at 34 cents,...
View Article(PFE) Pharma and Biotech Stock Outlook – August 2012 – Industry Outlook
The pharmaceutical industry is in the midst of one of the biggest patent cliffs with Pfizer’s (PFE) multi-billion-dollar blockbuster drug Lipitor losing patent protection in the US in late November...
View Article(SIRO) Sirona Dental Systems Brings Schick 33 to America
Dental technology leader Sirona Dental Systems, Inc. (SIRO) recently announced the launch of a novel intraoral digital sensor and image management system, the Schick 33. Patterson Dental, a unit of...
View Article(SIRO) Sirona Dental Systems Introduces CEREC Omnicam
Dental technology leader Sirona Dental Systems, Inc. (SIRO) recently introduced its latest intraoral camera, CEREC Omnicam. This new product is slated to enhance the company’s leading-edge CEREC...
View Article(ALGN) Align Technology Speaks on Growth Prospects
Recently, Align Technology (ALGN) participated at the Morgan Stanley Healthcare Conference where the Vice President, Finance and Chief Financial Officer of Align, Kenneth Arola clearly spoke about the...
View Article(ALGN) Align Technology’s Preliminary Third Quarter Sales Disappoint
A major player in the malocclusion market, Align Technology’s (ALGN) shares plunged 7.47% to close at $35.41 yesterday, following the release of its preliminary third quarter results that missed the...
View Article(MRK) Pharmaceuticals and Biotech Stock Outlook – December 2012 – Industry...
The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent times. The last few quarters saw major blockbusters like Merck’s (MRK) Singulair,...
View Article(JNJ) MedTech Industry Stock Outlook – January 2013 – Zacks Analyst Interviews
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide medical devices market. The US still holds the leading position with almost...
View Article(MRK) Pharma & Biotech Stock Outlook – Apr 2013 – Zacks Analyst Interviews
The pharmaceutical industry has been showing signs of recovery from one of the biggest patent cliffs in recent times. The last few quarters saw major blockbusters like Merck’s (MRK) Singulair, Pfizer’s...
View Article